Basics |
Exelixis, Inc. Common Stock
Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.
|
IPO Date: |
May 1, 2000 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$12.02B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.25 | 2.20%
|
Avg Daily Range (30 D): |
$0.84 | 1.86%
|
Avg Daily Range (90 D): |
$0.68 | 1.66%
|
Institutional Daily Volume |
Avg Daily Volume: |
2.05M |
Avg Daily Volume (30 D): |
2.27M |
Avg Daily Volume (90 D): |
2.38M |
Trade Size |
Avg Trade Size (Sh.): |
161 |
Avg Trade Size (Sh.) (30 D): |
62 |
Avg Trade Size (Sh.) (90 D): |
65 |
Institutional Trades |
Total Inst.Trades: |
11,739 |
Avg Inst. Trade: |
$2.85M |
Avg Inst. Trade (30 D): |
$6.39M |
Avg Inst. Trade (90 D): |
$5.29M |
Avg Inst. Trade Volume: |
.16M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$6.58M |
Avg Closing Trade (30 D): |
$27.07M |
Avg Closing Trade (90 D): |
$21.32M |
Avg Closing Volume: |
325.3K |
|
|
News |
Jul 20, 2025 @ 10:30 AM
Here's Why This $50 Healthcare Stock Could Be the ...
Source: Prosper Junior Bakiny
|
Jul 19, 2025 @ 10:09 AM
After Falling 68%, Where Will This Weight-Loss Dru...
Source: James Brumley
|
Jul 8, 2025 @ 2:25 PM
Amid NCI Budget Fears, Emerging Oncology Stocks Ga...
Source: Prnewswire
|
May 18, 2025 @ 8:06 PM
CoreWeave, Super Micro Computer And Coinbase Are A...
Source: Lekha Gupta
|
May 14, 2025 @ 6:43 PM
Tech Stocks Edge Up, AMD Rallies 5%, 30-Year Yield...
Source: Piero Cingari
|
Financials |
|
TTM |
Q1 2026 |
FY 2024 |
Basic EPS
|
|
$.57
|
$1.8
|
Diluted EPS
|
|
$.55
|
$1.76
|
Revenue
|
$
|
$ 555.45M
|
$ 2.17B
|
Gross Profit
|
$
|
$ 536.28M
|
$ 2.09B
|
Net Income / Loss
|
$
|
$ 159.62M
|
$ 521.27M
|
Operating Income / Loss
|
$
|
$ 186.86M
|
$ 604.62M
|
Cost of Revenue
|
$
|
$ 19.17M
|
$ 76.22M
|
Net Cash Flow
|
$
|
$ -33.62M
|
$ -45.62M
|
PE Ratio
|
|
|
|
|
|
|